OncoCyte Corp (NAS:OCX)
$ 2.435 -0.095 (-3.75%) Market Cap: 40.99 Mil Enterprise Value: 43.22 Mil PE Ratio: 0 PB Ratio: 3.34 GF Score: 31/100

OncoCyte Corp to Discuss Development and Co-Marketing Agreement with Thermo Fisher Scientific Inc Call Transcript

Jan 18, 2022 / 09:30PM GMT
Release Date Price: $43.8 (+15.87%)
Operator

Good day, and welcome to today's conference call to discuss Oncocyte's announcement of an agreement with Thermo Fisher Scientific. (Operator Instructions) Please note this conference is being recorded.

At this time, I would like to turn the call over to Bob Yedid of LifeSci Advisors. Please go ahead.

Robert A. Yedid
LifeSci Advisors, LLC - MD

Thank you, Shamali. Good day, and welcome to today's Oncocyte's call to discuss the announcement of a development and co-marketing agreement with Thermo Fisher Scientific to expand access to precision oncology. If you have not seen today's press release, please visit the company's website on the Investors page.

Before turning the call over to Ronnie Andrews, Oncocyte's President and Chief Executive Officer, I would like to remind you that during this conference call, the company will make projections and forward-looking statements regarding future events. Any statements that are not historical facts are forward-looking statements. We encourage you to review the company's SEC filings, including, without

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot